Atlas Trials

Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases

Clinical trial NCT03844750 · TERMINATED

Trial details

NCT number
NCT03844750
Sponsor
Chloe Atreya, MD, PhD
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8Stage IVB Colorectal Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8
Start date
2019-07-22
Primary completion
2025-09-30
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.